HIF-dependent Neuropeptide Y Receptor Y1 and Y5 expression sensitizes hypoxic cells to NPY stimulation
Authors:
Preprint
Abstract
Neuropeptide Y (NPY) is an abundant neurohormone in the central and peripheral nervous system involved in feeding behavior, energy balance, nociception, and anxiety. Several NPY receptor (NPYR) subtypes display elevated expression in many cancers including in breast cancer where this is exploited for imaging and diagnosis. Here, we show that NPY1R and NPY5R mRNA abundance is induced by hypoxia in a Hypoxia Inducible Factor (HIF)-dependent manner in breast cancer cell lines MCF7 and MDA-MB-231. The HIFs bind to several genomic regions upstream of the NPY1R and NPY5R transcription start sites. The MAPK/ERK pathway is activated more rapidly upon NPY5R stimulation in hypoxic cells compared to normoxic cells. This pathway requires IGF1R activity in normoxia, but not in hypoxic cells where they display resistance to the radiosensitizer and IGF1R inhibitor AG1024. Hypoxic cells proliferate and migrate more when stimulated with NPY relative to normoxic cells, with a more robust response observed with a Y5-specific agonist. Our data suggest that hypoxia induced NPYRs render hypoxic cells more sensitive to NPY stimulation. Considering that breast tissue receives a constant supply of NPY, and hypoxia is a common feature of the tumor microenvironment, breast tumors are the perfect storm for hyperactive NPYR. This study not only highlights a new relationship between the HIFs and NPYR expression and activity, but may inform the use of chemotherapeutics targeting NPYRs and hypoxic cells.Keywords
All Related Versions
- Published version: Journal of Biological Chemistry, 298 (3), 101645.
This publication has 43 references indexed in Scilit:
- Neuropeptide Y receptor mediates activation of ERK1/2 via transactivation of the IGF receptorCellular Signalling, 2015
- The intriguing mission of neuropeptide Y in the immune systemAmino Acids, 2011
- Neuropeptide Y stimulates proliferation and migration in the 4T1 breast cancer cell lineInternational Journal of Cancer, 2011
- The neuropeptide Y system: Pathophysiological and therapeutic implications in obesity and cancerPharmacology & Therapeutics, 2011
- Therapeutic potential of neuropeptide Y (NPY) receptor ligandsEMBO Molecular Medicine, 2010
- Neuropeptide Y Y5 Receptor Promotes Cell Growth through Extracellular Signal-Regulated Kinase Signaling and Cyclic AMP Inhibition in a Human Breast Cancer Cell LineMolecular Cancer Research, 2010
- Molecular characterization of the ligand-receptor interaction of the neuropeptide Y familyJournal of Peptide Science, 2000
- Neuropeptide Y (NPY) potentiates phenylephrine-induced mitogen-activated protein kinase activation in primary cardiomyocytes via NPY Y5 receptorsProceedings of the National Academy of Sciences, 2000
- Neuropeptide Y Y1 and Y2 receptor-mediated stimulation of mitogen-activated protein kinase activityRegulatory Peptides, 1998
- Cloning and Expression of a Novel Neuropeptide Y ReceptorJournal of Biological Chemistry, 1996